TGA Approval

MOVAPO apomorphine hydrochloride hemihydrate 50 mg/5 mL injection ampoule (142093)

ARTG ID

142093

ARTG Name

MOVAPO apomorphine hydrochloride hemihydrate 50 mg/5 mL injection ampoule

Sponsor

Stada Pharmaceuticals Australia Pty Ltd

ARTG Date

January 30, 2008

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

STADA PHARMACEUTICALS AUSTRALIA PTY LIMITED

https://medical-cdn.nocode.com/drug_tga/502d9dba92da781794ba9933445d3c2c.pdf

https://medical-cdn.nocode.com/drug_tga/e3b71d545fb4c8f2af48049db7d64a09.pdf

Ingredient Name

apomorphine hydrochloride hemihydrate

Empowering clinical research with data-driven insights and AI-powered tools.

MOVAPO apomorphine hydrochloride hemihydrate 50 mg/5 mL injection ampoule (142093) - TGA 批准文号 | MedPath